Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT03979508||Not yet recruiting||Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer||
||Other / NIH||
||100||Female||18 Years and older (Adult, Older Adult)||NCT03979508||MC1734
|October 1, 2019||July 31, 2022||July 31, 2022||June 7, 2019||August 19, 2019||